证券代码：002748 证券简称：世龙实业 公告编号：2025-043 江西世龙实业股份有限公司 关于选举第六届董事会职工代表董事的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 江西世龙实业股份有限公司（以下简称"公司"）于 2025 年 11 月 20 日召 开了 2025 年第二次临时股东大会，审议通过了《关于调整董事会成员人数并修 订<公司章程>的议案》。根据修订后的《公司章程》，公司董事会设职工代表董 事一名，由职工代表大会民主选举产生。 2 江西世龙实业股份有限公司 董 事 会 2025 年 11 月 21 日 1 附件：职工代表董事简历 熊珍丽：女，1976 年 10 月出生，中国国籍，无境外永久居留权，本科学历， 经济师职称。1996 年入职江西电化厂，历任电化公司企管办科员、电化精细公 司行政管理部主办、世龙实业总经办主任助理、副主任。现任公司总经办主任、 深圳龙蕃实业有限公司监事、江西电化乐丰化工股份有限公司监事。 截至目前，熊珍丽女士未持有本公司股票。其与持有公司 5%以上股份的股 东、其他董事、高级管理人员之间不存在关联关系，不存 ...

证券代码：002748 证券简称：世龙实业 公告编号：2025-042 江西世龙实业股份有限公司 2025 年第二次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会无新增、变更或否决提案的情况； 2、本次股东大会未涉及变更前次股东大会决议的情形。 一、股东大会的召开情况 1、会议召开时间： 现场会议时间：2025 年 11 月 20 日（星期四）下午 14：30 网络投票时间：通过深圳证券交易所交易系统投票的时间为 2025 年 11 月 2 0 日 9:15-9:25，9:30-11:30 和 13:00-15:00；通过深圳证券交易所互联网投票系统 进行网络投票的具体时间为 2025 年 11 月 20 日 9:15-15:00。 2、会议召开地点：江西省乐平市工业园区世龙科创大楼六楼会议室 3、会议召开方式：本次会议采取现场投票与网络投票相结合的方式 4、会议召集人：公司董事会 5、会议主持人：董事长汪国清先生 6、会议召开合法、合规性：本次股东大会的召开符合有关法律、法规和《公 司章程》的规定。 二、会 ...

江西省南昌市红谷滩区红谷中大道 1391 号华皓中心 53 层 53rd Floor, Huahao Center, No.1391 Honggu Middle Road, Honggutan District, Nanchang City, Jiangxi Province 电话/Tel.: 0791-86789099 网址/Website: www.kangdalawyers.com 北京 西安 深圳 海口 上海 广州 杭州 沈阳 南京 天津 菏泽 成都 苏州 呼和浩特 香港 武汉 郑州 长沙 厦门 重庆 合肥 宁波 济南 昆明 南昌 北京市康达（南昌）律师事务所 关于 本所律师出席了公司本次股东大会并审查了公司提供的有关召集、召 开本次股东大会的有关文件原件或复印件，同时听取了公司就相关事项的 第 1 页 共 14 页 江西世龙实业股份有限公司 2025 年第二次临时股东大会法律意见书 致：江西世龙实业股份有限公司 北京市康达（南昌）律师事务所（以下简称"本所"）接受江西世龙 实业股份有限公司（以下简称"公司"）的委托，指派本所潘莹律师、徐 楠律师（以下简称"本所律师"）出席公司 2025 年第二次临时 ...

Group 1 - Kanglongda's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 4.83 million shares [1] - The company specializes in the research, production, and sales of special and ordinary labor protection gloves [1] Group 2 - Haizheng Pharmaceutical's subsidiary plans to collaborate with East China Institute on a biological method for synthesizing heparin, with a project contract amount not exceeding 120 million yuan [2] - The company focuses on the research, production, and sales of chemical raw materials and formulations [3] Group 3 - Tianyin Holdings received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [4] - The company is engaged in the sales of smart terminals, e-commerce, lottery, mobile resale, and mobile internet businesses [4] Group 4 - Shanghai Yashi plans to use up to 200 million yuan of temporarily idle raised funds for cash management in high-security, liquid deposit products [5] - The company specializes in supply chain logistics and execution trade [6] Group 5 - Parker New Materials intends to use 130 million yuan of idle raised funds to purchase structured deposits with expected annual yields between 0.59% and 2.9001% [7] - The company focuses on the research, production, and sales of various types of ring forgings, free forgings, and die forgings [7] Group 6 - Huayang New Materials appointed Jing Hongsheng as the new general manager [8] Group 7 - Liyuan Technology's shareholder plans to reduce holdings by up to 2.03% of the company's shares, totaling no more than 3.04 million shares [9] - The company specializes in the research, design, and integration of environmental water treatment systems and hydrogen fuel cell engine systems [9] Group 8 - Shengnuo Biopharmaceutical's subsidiary received approval for the listing application of Visepegenatide raw materials, a GLP-1 receptor agonist for treating type 2 diabetes and obesity [10][11] - The company focuses on the research, production, and sales of peptide raw materials and formulations [10] Group 9 - Puluo Pharmaceutical plans to repurchase shares worth between 180 million and 360 million yuan, with a maximum price of 23 yuan per share [12] - The company specializes in the research, production, and sales of raw material intermediates and innovative drugs [12] Group 10 - Dongfang Electric's subsidiary plans to establish a joint venture with Anhui Waneng Energy, with a registered capital of approximately 1.857 billion yuan [13] - The company is involved in the development, design, manufacturing, and sales of advanced power generation equipment [13] Group 11 - Hefei China announced that its stock will resume trading on November 20 after completing a review of abnormal trading fluctuations [14] - The company focuses on international trade and after-sales services related to in vitro diagnostic medical devices [14] Group 12 - Dafeng Industrial won a bid for the stage equipment project of the Shenzhen International Performing Arts Center, with a contract amount of 165 million yuan [15] - The company specializes in cultural sports equipment, digital art technology, and operation services [15] Group 13 - Baiyunshan's subsidiary received a drug registration certificate for An Gong Niu Huang Wan in Vietnam [16] - The company is engaged in the research, manufacturing, and sales of traditional Chinese and Western medicines [16] Group 14 - Neusoft Group received a notification to supply intelligent cockpit domain controllers for multiple models from a well-known domestic automobile manufacturer, with an estimated total amount of about 4.2 billion yuan [17] - The company focuses on providing industry solutions and software products [17] Group 15 - Huayu Pharmaceutical's product received overseas marketing approval [18] - The company specializes in the research, production, and sales of innovative and high-quality generic drugs in the oncology field [18] Group 16 - Yao Pi Glass received approval from the CSRC for its stock issuance to specific investors [19] - The company specializes in the production and sales of float glass and processed glass [19] Group 17 - Guangyu Yuan's vice president Wang Junbo resigned due to work adjustments [20] - The company focuses on the production and sales of traditional Chinese medicine products [20] Group 18 - Biyi Co. received approval from the CSRC for its stock issuance to specific investors [21] - The company specializes in the design, manufacturing, and sales of smart small household appliances [21] Group 19 - Sunshine Nuohe's application for acquiring 100% equity of Jiangsu Langyan Life Science Technology Co., Ltd. through share issuance and convertible bonds has been accepted by the Shanghai Stock Exchange [22] - The company provides comprehensive drug research and development services for domestic pharmaceutical enterprises and research institutions [22] Group 20 - Longxin General plans to increase capital in its wholly-owned subsidiary by no more than 1.65 billion yuan [23] - The company specializes in the research, production, and sales of motorcycles and engines [23] Group 21 - Jiekang Equipment received a corrective order from the Tianjin Securities Regulatory Bureau due to internal control deficiencies [24] - The company specializes in the research, production, and sales of nuclear biochemical safety equipment [24] Group 22 - Wantong Technology plans to raise no more than 920 million yuan through a private placement to supplement working capital [25] - The company focuses on information technology services for highways and ports [25] Group 23 - Dongshan Precision has submitted an application for H-share listing to the Hong Kong Stock Exchange [26] - The company specializes in the research, production, and sales of electronic circuit products and precision components [26] Group 24 - Yonghe Intelligent Control plans to publicly transfer 100% equity of its wholly-owned subsidiary Kunming Medical Oncology Hospital [27] - The company specializes in water and heating valve fittings, tumor precision radiation therapy, and photovoltaic battery businesses [27] Group 25 - Aok Shares signed a strategic cooperation framework agreement with Suzhou Qitian New Materials Co., Ltd. [28] - The company focuses on the research and production of high-end new materials derived from ethylene oxide and ethylene [28] Group 26 - Hongquan Technology's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 299,440 shares [29] - The company specializes in the research, production, and sales of intelligent connected products and software platform development [29] Group 27 - Shilong Industrial's controlling shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 7.2 million shares [30] - The company specializes in the research, production, and sales of chemical products [30] Group 28 - Tangrenshen decided to terminate the investment in the "Dongchong Phase III Pig Breeding Base Construction Project," reallocating the remaining funds of 78.9587 million yuan to supplement working capital [31] - The company specializes in the research, production, and sales of feed, pigs, meat products, and animal health products [31] Group 29 - Gaode Infrared's actual controller plans to reduce holdings by up to 3% of the company's shares, totaling no more than 12.8 million shares [32] - The company specializes in infrared focal plane detector chips and infrared thermal imaging systems [32] Group 30 - Kangyuan Pharmaceutical's actual controller recently increased holdings by 20,000 shares [33] - The company specializes in the research, production, and sales of pharmaceuticals [33] Group 31 - Haida Group plans to repurchase shares worth between 1 billion and 1.6 billion yuan, with a maximum price of 62.00 yuan per share [34] - The company provides overall solutions for animal husbandry [34] Group 32 - Qizhong Technology's 850 million yuan convertible bonds have been approved for listing [35] - The company specializes in advanced packaging and testing of integrated circuits [35] Group 33 - Dingyang Technology launched the new SNA5000B series vector network analyzer [36] - The company specializes in the research, production, and sales of general electronic testing and measuring instruments [36] Group 34 - Airo Energy plans to distribute a cash dividend of 0.9375 yuan per share to all shareholders [37] - The company specializes in photovoltaic energy storage systems and products [37] Group 35 - Hechuan Technology's actual controller and some directors plan to reduce holdings by up to 6% of the company's shares [38] - The company specializes in the research, production, and sales of industrial automation products [38] Group 36 - China First Heavy Industries' chairman was arrested for suspected bribery [39] - The company specializes in heavy machinery manufacturing for various industries [39] Group 37 - Lianhuan Pharmaceutical plans to invest 15 million yuan in joint research with Nanjing University for anti-thrombotic small nucleic acid drugs [40] - The company specializes in the manufacturing and sales of chemical raw materials [40] Group 38 - Anxu Biotech's shareholder plans to reduce holdings by up to 0.94% of the company's shares, totaling no more than 120,000 shares [41] - The company specializes in the research, production, and sales of POCT reagents and instruments [41] Group 39 - Yaxiang Integration's shareholder reduced holdings by 130,000 shares [42] - The company specializes in providing cleanroom engineering and related services for high-tech electronic industries [42] Group 40 - Zhongwen Media plans to use up to 9.5 billion yuan of idle funds to purchase financial products [43] - The company specializes in traditional publishing and various new media businesses [43]

Core Viewpoint - Jiangxi Electric Chemical High-tech Co., Ltd. plans to reduce its holdings in Shilong Industrial by up to 7,200,000 shares, accounting for 3% of the total share capital, through centralized bidding and block trading over the next three months [1][3]. Group 1: Shareholding and Reduction Plan - Jiangxi Electric Chemical High-tech currently holds 18,400,000 shares of Shilong Industrial, representing 7.67% of the total share capital [3]. - The reduction plan includes a maximum of 2,400,000 shares (1% of total share capital) through centralized bidding and 4,800,000 shares (2% of total share capital) through block trading [1]. - The total cash expected from the reduction is approximately 91,368,000 yuan, based on the last closing price of 12.69 yuan per share [2]. Group 2: Company Background - Shilong Industrial was listed on the Shenzhen Stock Exchange on March 19, 2015, with an initial issuance of 30 million shares at a price of 15.38 yuan per share [3]. - The total funds raised during the IPO amounted to 46,140,000 yuan, with a net amount of 40,419,300 yuan after deducting issuance costs [3]. - The funds were intended for projects including the production of 50,000 tons of AC foaming agents and the expansion of chlorosulfonic acid production [3].

Core Insights - On November 18, several companies disclosed their shareholding changes, with 康缘药业, 超达装备, and 海大集团 announcing share buybacks, while 15 companies, including 立达信 and 艾布鲁, reported share reductions [1][2]. Group 1: Share Buybacks - 康缘药业's actual controller and director, 肖伟, increased his shareholding by 20,000 shares [2]. - 超达装备 secured a stock repurchase loan commitment from China Bank for up to 450 million yuan [2]. - 海大集团 plans to repurchase shares worth no less than 1 billion yuan and up to 1.6 billion yuan [2]. Group 2: Share Reductions - 立达信's shareholder, 李春华, intends to reduce his stake by no more than 1.56% [2]. - 艾布鲁's controlling shareholder, 钟儒波, plans to reduce his stake by no more than 3% [2]. - 高德红外's actual controller, 黄立, aims to reduce his stake by no more than 3% [2]. - 嘉美包装's shareholders plan to collectively reduce their stake by no more than 1.16% [2]. - 蓄奥规划's shareholders intend to reduce their stake by no more than 1% [2]. - 君逸数码's shareholder, 成都高创投, plans to reduce his stake by no more than 1% [2]. - 联合水务's shareholder, 上海衡联, intends to reduce his stake by no more than 0.14% [2]. - 亚翔集成's second-largest shareholder has reduced 130,000 shares and is still in the reduction period [2]. - 芯朋微's controlling shareholder, 张立新, has terminated his reduction plan early [2]. - 安旭生物's shareholder, 马华祥, plans to reduce his stake by no more than 0.94% [2]. - 农心科技's shareholder, 宁波农旗, intends to reduce his stake by no more than 0.54% [2]. - 禾川科技's actual controller and others plan to reduce their stake by no more than 6% [2]. - 世龙实业's shareholder, 电化高科, plans to reduce his stake by no more than 3% [2]. - 中国化学's executive, 聂宁新, intends to reduce his stake by no more than 60,000 shares [2]. - 鸿泉技术's shareholder, 千方科技, plans to reduce his stake by no more than 3% [2].

Core Points - The company, Jiangxi Shilong Industrial Co., Ltd., announced that its controlling shareholder, Jiangxi Dalong Industrial Co., Ltd., plans to reduce its stake in the company by selling up to 7,200,000 shares, which represents 3% of the total share capital [2] Summary by Category - **Shareholder Actions** - Jiangxi Electric Chemical High-tech Co., Ltd., an action-in-concert party of the controlling shareholder, holds 18,400,000 shares, accounting for 7.67% of the company's total share capital [2] - The planned reduction of shares will occur within three months after the announcement, starting 15 trading days from the date of the announcement [2]

Core Viewpoint - The company, Shilong Industrial, announced a plan for a significant share reduction by a major shareholder, which may impact its stock performance and investor sentiment [1] Company Summary - Shilong Industrial's controlling shareholder, Jiangxi Dalong Industrial Co., Ltd., and its concerted action partner, Jiangxi Electric Chemical High-tech Co., Ltd., plan to reduce their holdings by up to 7.2 million shares, representing 3% of the total share capital [1] - As of the announcement, Shilong Industrial's market capitalization is 3 billion yuan [1] Industry Summary - For the first half of 2025, Shilong Industrial's revenue composition is heavily weighted towards the chemical industry, accounting for 99.38%, with other businesses contributing only 0.46% and the thermal power sector at 0.16% [1]

Group 1 - The controlling shareholder's action partner, Jiangxi Electric Chemical High-tech Co., Ltd., holds 18.4 million shares, accounting for 7.67% of the total shares [1] - Jiangxi Electric Chemical High-tech Co., Ltd. plans to reduce its holdings by no more than 7.2 million shares, representing 3% of the total shares, within three months after the announcement date [1] - The reduction will include a maximum of 2.4 million shares through centralized bidding, accounting for 1%, and up to 4.8 million shares through block trading, accounting for 2% [1]

Core Viewpoint - Jiangxi Electric Chemical High-tech Co., Ltd. plans to reduce its stake in Shilong Industrial by up to 7.2 million shares, representing 3% of the total share capital, due to personal funding needs of the shareholder [1] Summary by Sections Shareholding and Reduction Plan - Jiangxi Electric Chemical High-tech Co., Ltd. currently holds 18.4 million shares in Shilong Industrial, accounting for 7.67% of the total share capital [1] - The reduction will occur within three months after the announcement, starting 15 trading days from the date of disclosure [1] - The reduction will be executed through centralized bidding and block trading, with a maximum of 2.4 million shares (1% of total share capital) through centralized bidding and 4.8 million shares (2% of total share capital) through block trading [1] Impact on Company - The planned reduction will not lead to a change in control of the company [1] - There will be no significant impact on the company's governance structure, equity structure, or ongoing operations [1]